Premarin
- Product NDC
- 0046-0749
- 11-digit product format
- 000460749
- Labeler code
- 0046
- Product ID
- 0046-0749_97a59d56-720c-42fd-86b7-00ad93752452
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CONJUGATED ESTROGENS
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- Application
- NDA010402
- Marketing category
- NDA
- Marketing start
- 1956-12-01
- Substance
- ESTROGENS, CONJUGATED
- Active strength
- 25 mg/5mL
- Pharmacologic classes
- Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N010402-001 | PREMARIN | ESTROGENS, CONJUGATED | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N010402-001 | PREMARIN | 25MG/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | cb3db0bc1861… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Premarin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ESTROGENS, CONJUGATED | 25 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| IU5QR144QX | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 87e2da8d-432c-4ed5-67a1-dc26294b2295 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d95be220-b30e-4165-a12d-f83825b0efb1 | Product name | 1 | 20160111 |
| 882e78d5-69f7-4a43-812f-1c1628241bbc | Product name | 1 | 20150910 |
| 2e1ce74f-4938-37b4-e2b4-cfd7971b45ea | Product name | 1 | 20140508 |
| d90784c3-64a2-2f23-9acd-d948d25bf235 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0046-0749-05 | Premarin | 5 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 5 | 22 | |
| 0046-0749-05 | Premarin | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | 22 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0046-0749-05 | EA - Each | 0046-0749 | 99bc58ba-fd6e-4cd8-bb09-11fd246c4937 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ESTROGENS, CONJUGATED | ACTIVE INGREDIENT | IU5QR144QX | PREMARIN (CONJUGATED ESTROGENS) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 12 | |
| ESTROGENS, CONJUGATED | ACTIVE MOIETY | IU5QR144QX | PREMARIN (CONJUGATED ESTROGENS) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 12 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | PREMARIN (CONJUGATED ESTROGENS) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 12 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | PREMARIN (CONJUGATED ESTROGENS) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0046-0749 | PREMARIN (CONJUGATED ESTROGENS) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [WYETH PHARMACEUTICALS LLC, A SUBSIDIARY OF PFIZER INC.] | 21 | Current NDC, Legacy NDC, 2 package rows | 20240308_87e2da8d-432c-4ed5-67a1-dc26294b2295.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Premarin | CONJUGATED ESTROGENS | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 87e2da8d-432c-4ed5-67a1-dc26294b2295 | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | 010402 NDA010402 0046-0749 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310203 | estrogens, conjugated 25 MG Injection | PSN | 87e2da8d-432c-4ed5-67a1-dc26294b2295 | 22 |
| 211975 | Premarin Intravenous 25 MG Injection | PSN | 87e2da8d-432c-4ed5-67a1-dc26294b2295 | 22 |
| 211975 | estrogens, conjugated (USP) 25 MG Injection [Premarin] | SBD | 87e2da8d-432c-4ed5-67a1-dc26294b2295 | 22 |
| 310203 | estrogens, conjugated (USP) 25 MG Injection | SCD | 87e2da8d-432c-4ed5-67a1-dc26294b2295 | 22 |
| 211975 | Premarin Intravenous 25 MG Injection | SY | 87e2da8d-432c-4ed5-67a1-dc26294b2295 | 22 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0046-0749-05 | 00046074905 | 1 VIAL in 1 CARTON (0046-0749-05) / 5 mL in 1 VIAL | 1 vial | 1956-12-01 | 0000-00-00 | No | No | Current |